Immune dysfunction and inflammation are the root cause of some of the hardest to diagnose and most devastating psychiatric disorders. In fact, up to 85% of them including ADHD, OCD, Schizophrenia, and Autism have immune-mediated causes. That’s why many patients don’t respond to traditional psychotropic medications and treatments.
In response, Moleculera created the Autoimmune Brain Panel, a series of five blood tests that identify the infections that lead to neuropsychiatric disorders. Clinically validated in more than 15,000 patients, the impact of Moleculera’s breakthrough has been both wide ranging and immediate. It is in market and has already been ordered by more than 2,500 doctors in 50 countries
Please sign up to watch this webinar with Moleculera Biosciences President and CEO, Craig Shimasaki, to learn how their innovative technology has the potential to improve millions of lives.
All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.